Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Specialty Sites
    • COVID-19
    • Practice Current
    • Practice Buzz
    • Without Borders
    • Equity, Diversity and Inclusion
    • Innovations in Care Delivery
  • Collections
    • Topics A-Z
    • Residents & Fellows
    • Infographics
    • Patient Pages
    • Null Hypothesis
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Residents & Fellows

Share

April 09, 2019; 92 (15 Supplement) May 7, 2019

GDAP1-Related Charcot-Marie-Tooth Disease: Additional Evidence for the c.692C>T Variant as a Pathogenic Mutation (P3.4-045)

Carolina Vivar, Jose David Avila
First published April 16, 2019,
Carolina Vivar
1Neurology, Geisinger Medical Center Danville PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose David Avila
1Neurology, Geisinger Medical Center Danville PA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Citation
GDAP1-Related Charcot-Marie-Tooth Disease: Additional Evidence for the c.692C>T Variant as a Pathogenic Mutation (P3.4-045)
Carolina Vivar, Jose David Avila
Neurology Apr 2019, 92 (15 Supplement) P3.4-045;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
0

Share

  • Article
  • Info & Disclosures
Loading

Abstract

Objective: To report a rare homozygous mutation in GDAP1 (Ganglioside-induced differentiation-associated protein 1) as a cause of autosomal recessive Charcot-Marie-Tooth disease (CMT).

Background: Mutations in GDAP1 represent up to 1% of all forms of CMT and 2–4% of autosomal recessive CMT (AR CMT). These mutations are associated with 4 CMT subtypes: CMT4A, CMT2H, CMTRIA and CMT2K. The most common phenotype is characterized by early onset of a motor predominant neuropathy with vocal cord paralysis and loss of ambulation by the second decade. The c.692C>T variant has only been reported in 3 siblings from a single Amish family with AR CMT.

Design/Methods: Case report and review of the literature.

Results: A 33 year-old man from Puerto Rico presented with weakness. He had normal motor milestones during early childhood but started falling at age 6. Symptoms progressed slowly over time. He developed hand weakness and bilateral foot drop a few years before his presentation. There was no family history of similar symptoms. Examination demonstrated distal weakness and atrophy involving the arms and legs, areflexia, and distal sensory loss. There was no extraocular, facial, bulbar or respiratory muscle weakness, and no upper motor neuron signs. An electrodiagnostic study demonstrated a non-length dependent, sensorimotor, primarily axonal neuropathy. Workup for acquired causes of neuropathy led to a new diagnosis of type 2 diabetes (Hemoglobin A1C 10.6%, normal <5.7%). Given the high clinical suspicion for a hereditary neuropathy, the patient underwent genetic testing, which identified a homozygous mutation c.692C>T (p.Pro231Leu) in GDAP1.

Conclusions: The c.692C>T mutation in GDAP1 is associated with AR CMT. Our case suggests that the mutation is not restricted to the Amish population. The phenotype seems to be milder compared to other forms of GDAP1-related AR CMT. In our case, diabetes likely contributed to the neuropathy but did not fully explain the phenotype.

Disclosure: Dr. Vivar has nothing to disclose. Dr. Avila has nothing to disclose.

Disputes & Debates: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Disputes & Debates Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
  • Info & Disclosures
Advertisement

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 96 (15)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2021 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise